Nanalysis Reports Fourth Quarter and Full Year 2021 Results

Hosting Call Today at 5pm ET

Nanalysis Scientific Corp. ("the Company", TSXV: NSCI OTCQX: NSCIF FRA: 1N1 ), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, releases its fourth quarter and full year results for year ending December 31, 2021 . Chief Executive Officer, Sean Krakiwsky and Chief Financial Officer, Luke Caplette will host a conference call at 5 P.M. Eastern Time today to discuss the results. All interested parties are invited to join this call.

Nanalysis Scientific Corp. Logo (CNW Group/Nanalysis Scientific Corp.)

"We are extremely proud to report a year of 100 per cent revenue growth," said Sean Krakiwsky , Founder and CEO of Nanalysis. "The recently announced acquisitions in early 2022 combined with our healthy balance sheet will provide the drivers from which we can build on our growing baseline business for the coming years. We plan to continue to expand our addressable markets, ensure synergies among our business divisions, and push organic sales of our existing product lines to maintain our growth trajectory for the foreseeable future."

Financial highlights for the twelve months ended December 31, 2021:

  • The Company reported consolidated revenue of $16,043K , an increase of $8,169K or 104% from the comparative period in 2020.
  • Gross margin was 64% for the twelve months ended December 31, 2021 compared to 66% for the twelve months ended December 31, 2020.
  • Income before other items for the twelve months ended December 31, 2021 was $1,905K an improvement of $3,549K compared to the same period last year.
  • Net loss for the twelve months ended December 31, 2021 was $1,772K , an improvement of $1,906K from the comparable period in 2020.
  • The Company had cash on hand of $10.4 million , an undrawn credit facility of $2.0 million and working capital of $12.1 million as of December 31, 2021 .

Financial highlights for the three months ended December 31, 2021:

  • The Company reported consolidated revenue of $5,077K , an increase of $2,397K or 89% from the comparative period in 2020.
  • Gross margin was 61% for the three months ended December 31, 2021 compared to 65% for the three months ended December 31, 2020.
  • Income before other items for the twelve months ended December 31, 2021 was $413K an improvement of $1,109K compared to the same period last year.
  • Net loss for the three months ended December 31, 2021 was $658K , an improvement of $567K from the comparable period in 2020.

Recent strategic and operational highlights during and subsequent to the fourth quarter of 2021 include:

  • Announced $4,985,000 Funding Contribution Commitment from the Canadian Government : The funding is provided through Prairies Economic Development Canada's Business Scale-up and Productivity program, which provides fast growing tech firms with support to scale-up and enter new markets. Nanalysis will draw down on the funds over the next three years with interest-free repayments commencing on September 1, 2025.
  • Closed Initial Equity Investment in Quad Systems : As part of the agreement, Nanalysis provided Quad Systems with a CHF 1,000,000 loan which is convertible into 40,000 shares in the capital of Quad Systems. Upon funding the loan, Sean Krakiwsky, founder and CEO of Nanalysis was appointed to Quad Systems' Board of Directors as Nanalysis' nominee. Pursuant to the subscription agreement entered into between the Company and Quad Systems, Nanalysis has been issued 260,000 Quad Systems shares for a subscription price of CHF 6,500,000 and two representatives of the Company will be appointed to Quad Systems' Board of Directors. Currently, Nanalysis owns 43% of Quad Systems. Additionally, until July 1, 2023 , Nanalysis has an option to acquire 100% of the issued and outstanding shares of Quad Systems at a pre-set valuation formula in a combination of cash and Nanalysis shares. During the Option Period, Nanalysis has a right of first refusal on all debt and equity offerings of Quad Systems.
  • Executed an Upsized Public Offering and Non-Brokered Private Placement For Gross Proceeds of $15,224,700 . On February 11, 2022 the Company closed a best efforts marketed public offering of common shares of the Company, including the full exercise of the over-allotment option and a non-brokered private placement of common shares for combined gross proceeds of $15.2 million . Pursuant to the terms of the public offering and non-brokered private placement the Company issued 13,840,637 common shares.
  • Closed of Acquisition of K'(Prime) Technologies Inc. in early January, 2022: K'Prime, a North American sales and service company, with a particular focus on scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems for security applications is being integrated into the Company.
Outlook

"The Company's objectives this year are to integrate the recent acquisitions, specifically K'Prime and Quad Systems. The former is going to allow the Company to continue to expand business with a full sales and service organization in multiple channels. Quad systems enables the Company to pursue the high-field part of the market while expanding product line offerings. The combination of both technology suites provides world class offerings," said Mr. Krakiwsky.

"Our core products, the 60Mhz and 100Mhz NMR benchtop units, continue to enjoy strong demand and we entered this year with a backlog of units and aggressive expansion plans to continue to meet demand."

"The recent acquisitions, a strong balance sheet, increased manufacturing capacity, access to capital through the funding contribution from the Federal government and continued demand for our existing products gives us confidence leading into 2022 and beyond. The foundation for success has been put into place and now management needs to execute to capitalize on this opportunity," concluded Mr. Krakiwsky.

Conference Call

Investors interested in participating on the live call can dial 1-888-664-6392 or 416-764-8659 from abroad. Investors can also access the call online through a listen-only webcast here: https://app.webinar.net/YQa2M3LDolK , or on the investor relations section of the Company's website HERE .

The webcast will be archived on the Company's investor relations webpage for at least 90 days and a telephonic playback will be available for seven days after the conference call by calling 1-888-390-0541 or 416-764-8677, conference ID #629645.

About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)

Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol 'NSCI', OTC and the Frankfurt exchange under the ticker symbol '1N1'. The company's business is what we term "MRI and NMR for industry". The company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. Nanalysis recently announced that it has begun selling a 100MHz device in 2020. The Company's new device will be the most powerful and most advanced compact NMR device ever brought to market.

Nanalysis devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners.

With the recent acquisition of K'Prime, the company maintains a North American sales and service company of over 40 individuals who cover scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems for security applications.

Additionally, the Company has a 43% ownership in Quad Systems AG ("Quad Systems"), with an option to purchase the remaining shares. Quad Systems is a Zurich -based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets.

Notice regarding Forward Looking Statements and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/nanalysis-reports-fourth-quarter-and-full-year-2021-results-301535765.html

SOURCE Nanalysis Scientific Corp.

Cision View original content to download multimedia: https://www.newswire.ca/en/releases/archive/April2022/28/c8332.html

News Provided by Canada Newswire via QuoteMedia

NSCI:CA
The Conversation (0)
XReality Group

Quarterly Activities Report and Appendix 4C - 30 Sept 24

xReality Group Limited (ASX:XRG) (xReality) is pleased to provide the following Quarterly Activities Report and Appendix 4C for the quarter ending 30th September 2024 together with an Operational Update.

Keep reading...Show less
Sona Nanotech Issued Patent and Appoints New Board Member

Sona Nanotech Issued Patent and Appoints New Board Member

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the issuance of U.S. Patent No. 12117447 by the U.S. Patent and Trademark Office to the Company, entitled, "Metal Nanoparticles and Methods of Making Same". This patent covers the Company's proprietary process for manufacturing gold nanorods without the use of the toxic substance, cetyltrimethylammonium bromide ("CTAB"), which typically carries significant cytotoxic and genotoxic risks.

The Company is also pleased to announce the appointment of Mr. Wayne Myles, KC, FIIC, to its board of directors. An active investor and entrepreneur, Mr. Myles has served as lead counsel and strategic business advisor on more than 100 domestic and international acquisitions and sales, financings, government and regulatory affairs and licensing mandates. He has significant and diverse experience as a director of public and private companies. He also has been recognized with numerous professional achievements, distinctions and awards, including being named as one of "Canada's Top 25 Most Influential Lawyers' by Canadian Lawyer Magazine."

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Four laptops around a device with a quantum symbol inside.

How to Invest in Quantum Computing Companies (Updated 2024)

Quantum computing is an emerging technology that has the potential to revolutionize many industries.

According to a late 2021 Statista forecast, the quantum computing market's total revenue is projected to reach US$8.6 billion by 2027. To put that into perspective, the industry was worth only US$412 million in 2020.

With that in mind, it's clear the field of quantum computing is nascent and exciting. Here the Investing News Network takes a look at what it is, its potential impact on several industries and how investors can get exposure to quantum computing through stocks, startups and exchange-traded funds.

Keep reading...Show less
XReality Group

Additional Funding Secured to Support Order Outlook

xReality Group Limited (“XRG” or the “Company”) is pleased to announce an additional $500,000 debt facility has been secured. The purpose of the additional drawdown is to increase inventory, accelerate the delivery of current projects and meet future orders.

Keep reading...Show less
Mockup of a person with a brain chip like the one Neuralink is creating.

Can You Invest in Elon Musk’s Neuralink? (Updated 2024)

Elon Musk's Neuralink has captured the public’s attention and imagination with its futuristic vision of connecting the human brain to computers.

A July 2024 report by IDTechEx projects that the overall brain computer interface market could reach a market value of over US$1.6 billion by 2045.

"We anticipate that the market for non-invasive solutions will grow before the commercialization of invasive solutions from players such as Neuralink," stated the research firm's Senior Technology Analyst Dr. Tess Skyrme. "However, the long-term opportunity within the assistive technology market is more likely to be captured by the likes of Elon Musk."

As Neuralink continues to make strides, investors are wondering how to get a piece of the action by investing in the neurotechnology venture.

Because it is privately held, Neuralink stock isn't accessible to the average person — but that doesn't mean its impossible to get exposure to this future-looking medical research company. Read on to learn how to participate in the growth of this exciting business.

Keep reading...Show less
E-Power Samples 37% Cg in New Discovery Area and 30% Cg at Advanced Target

E-Power Samples 37% Cg in New Discovery Area and 30% Cg at Advanced Target

E-Power Resources Inc. (CSE: EPR) ("E-Power" or the "Company") is pleased to report additional results from the 2024 exploration program on the Company's flagship Tetepisca flake graphite property located in the North Shore region of Québec.

Highlights include:

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×